Back to newsArcus Biosciences, Inc. <RCUS.N>: Truist Securities raises target price to $40 from $35RRCUS•2026-09-08Related NewsBFranklin Templeton To Buy Majority Stake In Stoneshield Capital
RCUS•RCUS•RCUS•RCUS•
